Corporate Corruption of Science—The Case of Chromium(VI)

Abstract

Corporate infiltration of a panel convened to set standards for chromium(VI) in California, buttressed by the engineered production of dubious "scientific" literature advancing industry's goal, succeeded in skewing the panel's decision to protect industry profits rather than public health. This situation demonstrates the insidious and effective influence of industry on the regulatory process.